Grant RadarWorldwide funding

Browse grants Log in Get started

Health Open for ApplicationsPAR-25-297

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

National Institutes of Health opportunity PAR-25-297

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthPAR-25-297Grants.gov

Related Grants

Understanding Cerebellar Contributions to Cognitive and Affective Functions in Aging and Alzheimer's Disease/Alzheimer's Disease-Related Dementias

Amount not stated

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Amount not stated

19 Oct 2027(347d)

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Amount not stated

07 May 2027(182d)

Resource and Capacity Building to Advance the Science of Aggression across Species and Disciplines (R24 Clinical Trial Optional)

Amount not stated

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Application Deadline

5 November 2027

364 days remaining

Opens: 4 Dec 2024

Programme Details

Programme Code

PAR-25-297